Both Intravenous and Inhaled Lidocaine Attenuate Reflex Bronchoconstriction but at Different Plasma Concentrations
Authors:
- 1 February 1999
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 159 (2) , 530-535
Abstract
Intravenous lidocaine can attenuate bronchial hyperreactivity. However, lidocaine inhalation might yield the same or better results at higher airway and lower lidocaine plasma concentrations. Therefore, we tested in awake volunteers with bronchial hyperreactivity the effect of lidocaine on histamine-induced bronchoconstriction administered either intravenously or as an aerosol. After approval of the local ethics committee, 15 volunteers were enrolled in this placebo-controlled, double-blinded, randomized study. Volunteers were selected by showing a decrease in FEV1 greater than 20% of baseline (PC20) in response to histamine inhalation. On three different days the challenge was repeated after pretreatment with either intravenous lidocaine, inhaled lidocaine, or placebo. Blood samples for determination of lidocaine plasma concentration were drawn. Comparisons were made using the Friedman and Wilcoxon signed-rank tests. Baseline PC20 was 6.4 ± 1.1 mg · ml− 1. Both inhalation of lidocaine and intravenous administration significantly increased PC20 to 14.8 ± 3.5 mg · ml− 1 and 14.2 ± 2.5 mg · ml− 1, respectively (p = 0.0007). Peak plasma lidocaine concentrations at the end of challenges were 0.7 ± 0.1 μ g · ml− 1 (inhaled) and 2.2 ± 0.1 μ g · ml− 1 (i.v.). However, 7 of 15 subjects showed an initial decrease of FEV1 greater than 5% following lidocaine inhalation. While both intravenous as well as inhaled lidocaine attenuate reflex bronchoconstriction significantly, lidocaine plasma concentrations are significantly lower after inhalation. However, the high incidence of initial bronchoconstriction to lidocaine inhalation may limit its use in patients with asthma and thus offers therapeutic advantages for intravenous lidocaine.Keywords
This publication has 25 references indexed in Scilit:
- Intravenous Lidocaine and Oral Mexiletine Block Reflex Bronchoconstriction in Asthmatic SubjectsAmerican Journal of Respiratory and Critical Care Medicine, 1996
- The contribution of neurogenic reflexes to hypertonic saline-induced bronchoconstriction in asthmaJournal of Allergy and Clinical Immunology, 1993
- Lidocaine-induced Bronchoconstriction in Asthmatic PatientsChest, 1989
- Tachyphylaxis to inhaled histamine in asthmatic subjectsJournal of Applied Physiology, 1987
- Central and local cholinergic components of histamine-induced bronchoconstriction in dogsJournal of Applied Physiology, 1985
- Fluorescence Polarization Immunoassay for the Determination of Therapeutic Drug Levels in Human PlasmaJournal of Analytical Toxicology, 1981
- Effects of Inhaled Lidocaine on Airway Function in Asthmatic SubjectsRespiration, 1979
- The Response to Lidocaine in Bronchial AsthmaChest, 1977
- Lidocaine and Increased Respiratory Resistance Produced by Ultrasonic AerosolsAnesthesiology, 1976
- Stimulation of lung irritant receptors by cigarette smoke, carbon dust, and histamine aerosol.Journal of Applied Physiology, 1971